VirTra price target lowered to $7.50 from $9.50 at Roth Capital

Roth Capital lowered the firm’s price target on VirTra (VTSI) to $7.50 from $9.50 and keeps a Buy rating on the shares after its Q4 results. Federal budget challenges and the shutdown dramatically curtailed revenues, but bookings of $7.3M were fair and backlog rose to $25.6M, up 17% from Q3, the analyst tells investors in a research note. The stock’s defensibility is “good in the interim”, the firm added.